ZIOP - ZIOPHARM Oncology Inc. (ZIOP) CEO Kevin Boyle on Q3 2021 Results - Earnings Call Transcript
ZIOPHARM Oncology, Inc. (ZIOP) Q3 2021 Earnings Conference Call November 08, 2021, 04:30 PM ET Company Participants Kevin Boyle – CEO Alex Lobo – Chair Investor Relations Raffaele Baffa – Chief Medical Officer Conference Call Participants Emily Milligan – Cantor Fitzgerald Arthur Hey – H.C. Thomas Flaten – Lake Street Capital Markets Presentation Operator Greetings. Welcome to ZIOPHARM Oncology Third Quarter 2021 earnings conference call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone should require Operator assistance during the conference, please press star 0 on your telephone keypad. Please note this conference is being recorded. I will now turn the conference over to your host, Alex Lobo, Chair Investor Relations. Thank you. You may begin. Alex Lobo Thank you. Good afternoon and welcome ZIOPHARM Oncology's third quarter of 2021 financial results conference call and audio webcast. With me
For further details see:
ZIOPHARM Oncology, Inc. (ZIOP) CEO Kevin Boyle on Q3 2021 Results - Earnings Call Transcript